Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
82
NMPA:82
Drug Approvals
Duloxetine Hydrochloride Enteric Capsules
- Product Name
- 盐酸度洛西汀肠溶胶囊
- Approval Number
- 国药准字H20254131
- Approval Date
- May 13, 2025
NMPA
Duloxetine Hydrochloride Enteric Capsules
- Product Name
- 盐酸度洛西汀肠溶胶囊
- Approval Number
- 国药准字H20254133
- Approval Date
- May 13, 2025
NMPA
Duloxetine Hydrochloride Enteric Capsules
- Product Name
- 盐酸度洛西汀肠溶胶囊
- Approval Number
- 国药准字H20254132
- Approval Date
- May 13, 2025
NMPA
Rivastigmine Hydrogen Tartrate Capsules
- Product Name
- 重酒石酸卡巴拉汀胶囊
- Approval Number
- 国药准字H20203011
- Approval Date
- Oct 16, 2024
NMPA
Rivastigmine Hydrogen Tartrate Capsules
- Product Name
- 重酒石酸卡巴拉汀胶囊
- Approval Number
- 国药准字H20203012
- Approval Date
- Oct 16, 2024
NMPA
Nicergoline for Injection
- Product Name
- 注射用尼麦角林
- Approval Number
- 国药准字H20084284
- Approval Date
- Aug 22, 2024
NMPA
Nicergoline for Injection
- Product Name
- 注射用尼麦角林
- Approval Number
- 国药准字H20084283
- Approval Date
- Aug 22, 2024
NMPA
Nicergoline for Injection
- Product Name
- 注射用尼麦角林
- Approval Number
- 国药准字H20084282
- Approval Date
- Aug 22, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found